These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 10543448)

  • 1. Biochemical characterization of the catalytic domain of membrane-type 4 matrix metalloproteinase.
    Kolkenbrock H; Essers L; Ulbrich N; Will H
    Biol Chem; 1999 Sep; 380(9):1103-8. PubMed ID: 10543448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
    Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.
    Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K
    EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
    Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.
    Li H; Bauzon DE; Xu X; Tschesche H; Cao J; Sang QA
    Mol Carcinog; 1998 Jun; 22(2):84-94. PubMed ID: 9655252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma.
    Puente XS; Pendás AM; Llano E; Velasco G; López-Otín C
    Cancer Res; 1996 Mar; 56(5):944-9. PubMed ID: 8640782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human MT6-matrix metalloproteinase: identification, progelatinase A activation, and expression in brain tumors.
    Velasco G; Cal S; Merlos-Suárez A; Ferrando AA; Alvarez S; Nakano A; Arribas J; López-Otín C
    Cancer Res; 2000 Feb; 60(4):877-82. PubMed ID: 10706098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity.
    Uría JA; López-Otín C
    Cancer Res; 2000 Sep; 60(17):4745-51. PubMed ID: 10987280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).
    English WR; Velasco G; Stracke JO; Knäuper V; Murphy G
    FEBS Lett; 2001 Feb; 491(1-2):137-42. PubMed ID: 11226436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.
    Itoh Y; Takamura A; Ito N; Maru Y; Sato H; Suenaga N; Aoki T; Seiki M
    EMBO J; 2001 Sep; 20(17):4782-93. PubMed ID: 11532942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct activation of pro-matrix metalloproteinase-2 by leukolysin/membrane-type 6 matrix metalloproteinase/matrix metalloproteinase 25 at the asn(109)-Tyr bond.
    Nie J; Pei D
    Cancer Res; 2003 Oct; 63(20):6758-62. PubMed ID: 14583471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic activities and substrate specificity of the human membrane type 4 matrix metalloproteinase catalytic domain.
    Wang Y; Johnson AR; Ye QZ; Dyer RD
    J Biol Chem; 1999 Nov; 274(46):33043-9. PubMed ID: 10551873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase.
    Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H
    Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S; Lehti K; Keski-Oja J; Mignatti P
    J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukolysin/MMP25/MT6-MMP: a novel matrix metalloproteinase specifically expressed in the leukocyte lineage.
    Pei D
    Cell Res; 1999 Dec; 9(4):291-303. PubMed ID: 10628838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3.
    Will H; Atkinson SJ; Butler GS; Smith B; Murphy G
    J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.